1Laboratory for Drug Discovery in Neurodegeneration, Department of Neurology, Harvard Medical School, Cambridge, MA 02139, USA. rstein@rics.bwh.harvard.edu
Academic scientists are adopting high-throughput screening (HTS) for drug discovery and chemical genetics. This approach enables testing novel hypotheses and discovering new biologic modulators.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: